Can a basal cell carcinoma convert into squamous cell carcinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can a Basal Cell Carcinoma Transform into Squamous Cell Carcinoma?

Yes, a basal cell carcinoma can undergo partial squamous metaplasia and develop squamous cell carcinoma features, creating what is known as a basosquamous carcinoma—a truly biphenotypic tumor that should be treated as squamous cell carcinoma due to its higher metastatic potential. 1

Understanding Basosquamous Carcinoma

The National Comprehensive Cancer Network recognizes two distinct mechanisms by which a lesion can contain both basal and squamous cell features: 1

Two Pathways of Development

  • Collision tumors: Some basosquamous carcinomas result from a basal cell cancer physically colliding with an adjacent squamous cell cancer 1

  • True transformation: Others represent genuinely biphenotypic tumors, many of which may have started as basal cell cancer but subsequently underwent prominent partial squamous metaplasia 1

Histologic Characteristics

  • These tumors display one area with histologic appearance of basal cell carcinoma and another area with squamous cell carcinoma features 1

  • A transition zone typically links the two components 2

  • The squamous component determines the tumor's metastatic risk 1

Critical Clinical Implications

Treatment Approach

Basosquamous carcinomas must be conceptualized and treated as squamous cell cancers, not basal cell cancers, because their metastatic capacity resembles squamous cell carcinoma rather than basal cell carcinoma. 1

Why This Matters for Morbidity and Mortality

  • Basal cell carcinomas rarely metastasize and have excellent prognosis 3, 4

  • Squamous cell carcinomas have significantly higher metastatic potential 1

  • The squamous component in basosquamous tumors confers the higher-risk behavior pattern 1

  • Several studies demonstrate that basosquamous carcinomas have metastatic capacity more similar to squamous cell cancer than basal cell cancer 1

Risk Stratification

When a basosquamous carcinoma is identified, assess for high-risk features that increase recurrence and metastasis risk: 1, 5

  • Perineural involvement (significantly increases risk) 1, 5
  • Poor differentiation 1, 5
  • Desmoplastic features 1, 5
  • Deep invasion into reticular dermis or subcutaneous fat 1, 5
  • Rapidly growing tumor 1
  • Location at site of chronic inflammation or scarring 1

Common Pitfalls to Avoid

  • Do not treat basosquamous carcinoma as a low-risk basal cell carcinoma—this underestimates metastatic potential and may lead to inadequate treatment 1

  • Ensure adequate biopsy sampling—superficial biopsies may miss the squamous component, leading to misclassification 2, 6

  • Do not rely solely on clinical appearance—dermoscopic features show BCC-dominant vasculature with SCC-dominant morphology, making clinical diagnosis challenging 6

Diagnostic Confirmation

  • Histopathological examination is essential for definitive diagnosis 7, 8

  • Immunohistochemistry can help differentiate components: Ber-EP4 is positive in BCC areas with diminished staining in transition zones 2

  • The biopsy should sample the most abnormal-appearing area to capture both components 3

References

Guideline

basal cell and squamous cell skin cancers.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Guideline

Superficially Invasive Squamous Cell Carcinoma: Aggressiveness Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Basosquamous carcinoma: Dermoscopic clues to diagnosis.

The Journal of dermatology, 2017

Guideline

Atrophic Patterns Affecting Basal Cells in Dermatological Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.